allow review safety data independent committee astrazeneca said statement routine action happen potentially unexplained illness trials investigated working expedite review single event minimize potential impact trial timeline committed safety participants highest standards conduct trials statement notes event linked definitively probably vaccine definitive blow particular vaccine candidate unrelated hold lifted matter weeks says kieny details adverse event including happened difficult assess impact trials timeline vaccine approval scientists second time administration vaccine paused uk according people took study information sheets uploaded clinical trial registry previously participant developed symptoms transverse myelitis inflammation spinal cord sparked viral infections according safety review trial resumed individual